WT1 peptide-loaded dendritic cell product

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameWT1 peptide-loaded dendritic cell product

Drug Alias NameWT1多肽负载树突状细胞产品Peptivator-pulsed dendritic cell vaccine

ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulantsWilms' Tumour 1 (WT1)-directed cytolytic effects

TargetsWilms' Tumour 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesMedinet

China Registration ClassN/A

Develop Information

Active CompaniesMedinet

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A